Eventos
Sorafenib downregulates nuclear factor E2-related factor 2 (Nrf2)-regulated thioredoxin 1 (Trx1) expression impacting cell survival in liver cancer cells
Sorafenib downregulates nuclear factor E2-related factor 2 (Nrf2)-regulated thioredoxin 1 (Trx1) expression impacting cell survival in liver cancer cells
| Título | Sorafenib downregulates nuclear factor E2-related factor 2 (Nrf2)-regulated thioredoxin 1 (Trx1) expression impacting cell survival in liver cancer cells |
|---|---|
| Fecha event | 26/10/2022 08:30 → 26/10/2022 10:00 |
| Entidad | IBiS |
| Lugar |
Salón de Actos IBiS |
| Organizador | IBiS |
| Ponentes | Dr. Jordi Muntané Co-Investigador Responsable Grupo IBiS Cirugía Oncológica. Terapia celular y trasplante de órganos |
| Cartel/Poster |
|